Literature DB >> 16536469

Interaction of c(60)-fullerene and carboxyfullerene with proteins: docking and binding site alignment.

Hadar Benyamini1, Alexandra Shulman-Peleg, Haim J Wolfson, Bogdan Belgorodsky, Ludmila Fadeev, Michael Gozin.   

Abstract

The unique properties of fullerenes have raised the interest of using them for biomedical applications. Within this framework, the interactions of fullerenes with proteins have been an exciting research target, yet little is known about how native proteins can bind fullerenes, and what is the nature of these interactions. Moreover, though some proteins have been shown to interact with fullerenes, up to date, no crystal structure of such complexes was obtained. Here we report docking studies aimed at examining the interactions of fullerene in two forms (C60 nonsubstituted fullerene and carboxyfullerene) with four proteins that are known to bind fullerene derivatives: HIV protease, fullerene-specific antibody, human serum albumin, and bovine serum albumin. Our work provides docking models with detailed binding pockets information, which closely match available experimental data. We further compare the predicted binding sites using a novel multiple binding site alignment method. A high similarity between the physicochemical properties and surface geometry was found for fullerene's binding sites of HIV protease and the human and bovine serum albumins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16536469     DOI: 10.1021/bc050299g

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  13 in total

1.  Binding of single walled carbon nanotube to WT and mutant HIV-1 proteases: analysis of flap dynamics and binding mechanism.

Authors:  Biswa Ranjan Meher; Yixuan Wang
Journal:  J Mol Graph Model       Date:  2012-10-13       Impact factor: 2.518

Review 2.  Chemical basis of interactions between engineered nanoparticles and biological systems.

Authors:  Qingxin Mu; Guibin Jiang; Lingxin Chen; Hongyu Zhou; Denis Fourches; Alexander Tropsha; Bing Yan
Journal:  Chem Rev       Date:  2014-06-13       Impact factor: 60.622

3.  Computational studies of the binding mechanisms of fullerenes to human serum albumin.

Authors:  Jinyu Li; Lizhi Jiang; Xiaolei Zhu
Journal:  J Mol Model       Date:  2015-06-21       Impact factor: 1.810

Review 4.  Nanomedicine--challenge and perspectives.

Authors:  Kristina Riehemann; Stefan W Schneider; Thomas A Luger; Biana Godin; Mauro Ferrari; Harald Fuchs
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

5.  Good's Buffer Ionic Liquids as Relevant Phase-Forming Components of Self-Buffered Aqueous Biphasic Systems.

Authors:  Mohamed Taha; Maria V Quental; Francisca A E Silva; Emanuel V Capela; Mara G Freire; Sónia P M Ventura; João A P Coutinho
Journal:  J Chem Technol Biotechnol       Date:  2017-02-01       Impact factor: 3.174

6.  Comparison of PGH2 binding site in prostaglandin synthases.

Authors:  Padmapriya Paragi-Vedanthi; Mukesh Doble
Journal:  BMC Bioinformatics       Date:  2010-01-18       Impact factor: 3.169

7.  Interaction of human serum album and C₆₀ aggregates in solution.

Authors:  Maoyong Song; Shufang Liu; Junfa Yin; Hailin Wang
Journal:  Int J Mol Sci       Date:  2011-08-04       Impact factor: 5.923

8.  Good's buffers as a basis for developing self-buffering and biocompatible ionic liquids for biological research.

Authors:  Mohamed Taha; Francisca A E Silva; Maria V Quental; Sónia P M Ventura; Mara G Freire; João A P Coutinho
Journal:  Green Chem       Date:  2014-06-01       Impact factor: 10.182

9.  Spectroscopic study on the interaction of pristine C60 and serum albumins in solution.

Authors:  Shufang Liu; Yu Sui; Kai Guo; Zhijuan Yin; Xibao Gao
Journal:  Nanoscale Res Lett       Date:  2012-08-02       Impact factor: 4.703

10.  In Silico Approach for SAR Analysis of the Predicted Model of DEPDC1B: A Novel Target for Oral Cancer.

Authors:  Palak Ahuja; Kailash Singh
Journal:  Adv Bioinformatics       Date:  2016-02-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.